US Stock Movement | Added to Nasdaq 100 Index, Moderna (MRNA.US) rises 7%

Zhito Finance APP has learned that on Friday, Moderna (MRNA.US) rose as much as 10% during intraday trading, with its stock price hitting a new high since December 2022. As of press time, the gain had narrowed to 7%, at $210.95. On the news front, on October 9, Moderna was officially included in the Nasdaq 100 Index, replacing Warner Bros. Discovery. Following its inclusion, some broad-based institutions that previously did not allocate to biopharmaceuticals will hold the stock passively, and active institutions will also add the company to their watchlists, increasing attention to the stock.